CRBN and cancer: Furthermore, according to Spearman correlation between GSPT1 and the 10 most frequently utilized E3 ligases, the expression levels of CRBN in various cancer types are not prominent; thus, we predicted the possibility of developing MGDs targeting other E3 ligases in the future (Figure 6D,E).